Zydus Lifesciences Ltd.

Zydus Lifesciences has enclosed a copy of press release dated November 26, 2025, titled ‘Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.